Compare Stocks: CPIX, ASMB, CGC, and EOLS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASMB Assembly Biosciences	$35.70 +1.0%	$27.58	$20.23 ▼ $39.71	$722.17M	1.1	160,907 shs	52,026 shs
CGC Canopy Growth	$1.05 -2.3%	$0.96	$0.84 ▼ $2.38	$469.52M	0.81	8.67 million shs	1.01 million shs
CPIX Cumberland Pharmaceuticals	$8.77 +0.7%	$6.97	$1.85 ▼ $8.95	$131.67M	0.08	461,897 shs	17,137 shs
EOLS Evolus	$8.99 +0.1%	$6.91	$3.86 ▼ $9.12	$593.46M	1.35	1.03 million shs	328,460 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASMB Assembly Biosciences	+0.14%	+9.96%	+38.28%	+28.94%	+32.72%
CGC Canopy Growth	+1.90%	+8.11%	+20.22%	0.00%	-25.69%
CPIX Cumberland Pharmaceuticals	+10.97%	+14.02%	+31.62%	+48.46%	+166.87%
EOLS Evolus	+2.28%	+9.78%	+50.17%	+45.31%	+20.86%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ASMB Assembly Biosciences	$35.70 +1.0%	$27.58	$20.23 ▼ $39.71	$722.17M	1.1	160,907 shs	52,026 shs
CGC Canopy Growth	$1.05 -2.3%	$0.96	$0.84 ▼ $2.38	$469.52M	0.81	8.67 million shs	1.01 million shs
CPIX Cumberland Pharmaceuticals	$8.77 +0.7%	$6.97	$1.85 ▼ $8.95	$131.67M	0.08	461,897 shs	17,137 shs
EOLS Evolus	$8.99 +0.1%	$6.91	$3.86 ▼ $9.12	$593.46M	1.35	1.03 million shs	328,460 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ASMB Assembly Biosciences	+0.14%	+9.96%	+38.28%	+28.94%	+32.72%
CGC Canopy Growth	+1.90%	+8.11%	+20.22%	0.00%	-25.69%
CPIX Cumberland Pharmaceuticals	+10.97%	+14.02%	+31.62%	+48.46%	+166.87%
EOLS Evolus	+2.28%	+9.78%	+50.17%	+45.31%	+20.86%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ASMB Assembly Biosciences	2.86	Moderate Buy	$44.00	23.26% Upside
CGC Canopy Growth	2.20	Hold	N/A	N/A
CPIX Cumberland Pharmaceuticals	1.00	Sell	N/A	N/A
EOLS Evolus	2.50	Moderate Buy	$14.50	61.38% Upside

Current Analyst Ratings Breakdown

Latest CPIX, ASMB, CGC, and EOLS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	EOLS Evolus	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$13.00
8/20/2026	ASMB Assembly Biosciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/18/2026	ASMB Assembly Biosciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$50.00
8/12/2026	CGC Canopy Growth	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/29/2026	CGC Canopy Growth	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	ASMB Assembly Biosciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/14/2026	CGC Canopy Growth	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/29/2026	CGC Canopy Growth	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/24/2026	CPIX Cumberland Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/17/2026	EOLS Evolus	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$13.00
6/15/2026	CGC Canopy Growth	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 8/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ASMB Assembly Biosciences	$72.30M	10.05	N/A	N/A	$15.01 per share	2.38
CGC Canopy Growth	$251.01M	1.87	N/A	N/A	$1.11 per share	0.94
CPIX Cumberland Pharmaceuticals	$44.52M	2.95	$0.41 per share	21.38	$1.14 per share	7.69
EOLS Evolus	$297.18M	2.00	N/A	N/A	($0.47) per share	-19.12

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ASMB Assembly Biosciences	-$6.12M	$1.02	34.77	N/A	N/A	-0.06%	-0.02%	-0.02%	11/9/2026 (Estimated)
CGC Canopy Growth	-$190.29M	-$0.45	N/A	N/A	N/A	-65.33%	-21.91%	-14.34%	11/6/2026 (Estimated)
CPIX Cumberland Pharmaceuticals	-$2.84M	-$0.71	N/A	N/A	N/A	-34.40%	-28.81%	-9.25%	11/3/2026 (Estimated)
EOLS Evolus	-$51.64M	-$0.52	N/A	112.31	N/A	-10.85%	N/A	-13.00%	11/4/2026 (Estimated)

Latest CPIX, ASMB, CGC, and EOLS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	ASMB Assembly Biosciences	-$0.7242	-$0.20	+$0.5242	-$0.20	$8.60 million	$13.37 million
8/7/2026	Q1 2027	CGC Canopy Growth	-$0.04	-$0.02	+$0.02	-$0.02	$58.21 million	$142.62 million
8/4/2026	Q2 2026	CPIX Cumberland Pharmaceuticals	-$0.13	-$0.20	-$0.07	-$0.29	$8.50 million	$0.17 million
6/15/2026	Q4 2026	CGC Canopy Growth	-$0.06	-$0.17	-$0.11	-$0.05	$53.43 million	$51.22 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ASMB Assembly Biosciences	N/A	N/A	N/A	N/A	N/A
CGC Canopy Growth	N/A	N/A	N/A	N/A	N/A
CPIX Cumberland Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
EOLS Evolus	N/A	N/A	N/A	N/A	N/A

Latest CPIX, ASMB, CGC, and EOLS Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/13/2026	CPIX Cumberland Pharmaceuticals		$1.50			7/23/2026	7/31/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ASMB Assembly Biosciences	N/A	13.99	13.99
CGC Canopy Growth	0.31	3.04	2.39
CPIX Cumberland Pharmaceuticals	N/A	0.96	0.96
EOLS Evolus	N/A	1.70	1.28

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ASMB Assembly Biosciences	19.92%
CGC Canopy Growth	3.33%
CPIX Cumberland Pharmaceuticals	15.51%
EOLS Evolus	90.69%

Insider Ownership

Company	Insider Ownership
ASMB Assembly Biosciences	3.50%
CGC Canopy Growth	0.35%
CPIX Cumberland Pharmaceuticals	42.07%
EOLS Evolus	5.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ASMB Assembly Biosciences	100	20.36 million	19.65 million	Optionable
CGC Canopy Growth	1,128	449.30 million	447.73 million	Optionable
CPIX Cumberland Pharmaceuticals	80	14.98 million	8.68 million	Optionable
EOLS Evolus	170	66.05 million	62.75 million	Optionable

CPIX, ASMB, CGC, and EOLS Headlines

Recent News About These Companies

Evolus' (EOLS) "Buy" Rating Reaffirmed at HC Wainwright

August 25 at 8:05 AM | marketbeat.com

Evolus (NASDAQ:EOLS) Reaches New 1-Year High - What's Next?

August 25 at 3:42 AM | americanbankingnews.com

Evolus (NASDAQ:EOLS) Reaches New 52-Week High - Time to Buy?

August 25 at 3:39 AM | marketbeat.com

Evolus, Inc. (NASDAQ:EOLS) Receives Average Recommendation of "Moderate Buy" from Analysts

August 24 at 10:13 AM | marketbeat.com

Evolus (NASDAQ:EOLS) Reaches New 12-Month High - Time to Buy?

August 19, 2026 | marketbeat.com

1,289,888 Shares in Evolus, Inc. $EOLS Purchased by Rice Hall James & Associates LLC

August 18, 2026 | marketbeat.com

Renaissance Technologies LLC Lowers Stake in Evolus, Inc. $EOLS

August 13, 2026 | marketbeat.com

Assenagon Asset Management S.A. Grows Stock Holdings in Evolus, Inc. $EOLS

August 12, 2026 | marketbeat.com

Evolus: The Injectable Platform Is Becoming The Real Moat

August 11, 2026 | seekingalpha.com

Evolus (NASDAQ:EOLS) Reaches New 1-Year High - Here's What Happened

August 11, 2026 | marketbeat.com

Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade

August 11, 2026 | zacks.com

Evolus (NASDAQ:EOLS) Rating Increased to Buy at Wall Street Zen

August 8, 2026 | marketbeat.com

Evolus, Inc. 2026 Q2 - Results - Earnings Call Presentation

August 6, 2026 | seekingalpha.com

Evolus, Inc. (EOLS) Q2 2026 Earnings Call Transcript

August 6, 2026 | seekingalpha.com

Evolus (NASDAQ:EOLS) Posts Earnings Results, Misses Expectations By $0.08 EPS

August 5, 2026 | marketbeat.com

Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2

August 5, 2026 | zacks.com

Evolus Q2 Earnings Call Highlights

August 5, 2026 | marketbeat.com

Evolus Inc. Earnings Call Signals Confident Growth

August 5, 2026 | tipranks.com

Evolus (EOLS) Releases Q2 2026 Earnings: Revenue Growth and Narrower Losses

August 5, 2026 | quiverquant.comQ

Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook

August 5, 2026 | businesswire.com

Evolus Expands Symatese Partnership into Three New Markets

August 4, 2026 | ocbj.comO

New MarketBeat Followers Over Time

Media Sentiment Over Time

CPIX, ASMB, CGC, and EOLS Company Descriptions

Assembly Biosciences NASDAQ:ASMB

$35.70 +0.37 (+1.04%)

As of 11:32 AM Eastern

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Canopy Growth NASDAQ:CGC

$1.04 -0.03 (-2.34%)

As of 11:31 AM Eastern

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Cumberland Pharmaceuticals NASDAQ:CPIX

$8.76 +0.07 (+0.75%)

As of 11:31 AM Eastern

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Evolus NASDAQ:EOLS

$8.98 +0.01 (+0.06%)

As of 11:32 AM Eastern

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CPIX, ASMB, CGC, and EOLS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CPIX, ASMB, CGC, and EOLS Earnings

Compare Dividends

Latest CPIX, ASMB, CGC, and EOLS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CPIX, ASMB, CGC, and EOLS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CPIX, ASMB, CGC, and EOLS Company Descriptions

Assembly Biosciences NASDAQ:ASMB

Canopy Growth NASDAQ:CGC

Cumberland Pharmaceuticals NASDAQ:CPIX

Evolus NASDAQ:EOLS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CPIX, ASMB, CGC, and EOLS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CPIX, ASMB, CGC, and EOLS Earnings

Compare Dividends

Latest CPIX, ASMB, CGC, and EOLS Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CPIX, ASMB, CGC, and EOLS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CPIX, ASMB, CGC, and EOLS Company Descriptions

Assembly Biosciences NASDAQ:ASMB

Canopy Growth NASDAQ:CGC

Cumberland Pharmaceuticals NASDAQ:CPIX

Evolus NASDAQ:EOLS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools